News | July 22, 2008

CardiArc SPECT Imaging System Up for Clinical Trials at Cleveland Clinic, Emory

July 23, 2008 - Independent research institutions will put the CardiArc SPECT system from CardiArc Inc, Southfield, MI, to the test. Both Cleveland Clinic, Cleveland, and Emory University, Atlanta, will evaluate the performance and design of the cardiovascular camera in clinical settings.

The unit is designed specifically for cardiac imaging, particularly for coronary artery disease detection. SPECT, or single photon emission computed tomography, noninvasively creates 3D images that show the blood flow and function of major organs, such as the heart.

The company said its main goal is looking for comparisons with regular patients on conventional types of SPECT imaging when looking for coronary artery disease. The research programs will explore how the CardiArc system stacks up to other SPECT systems.

Cleveland Clinic will compare the scans of 100 patients who will be scanned by both the CardiArc SPECT system and the facility’s current clinical SPECT machine. Researchers also will compile a database of CardiArc scans that show diseased hearts as well as normal hearts both at rest and under stress. Emory University will perform similar research with a pool of 200 patients.

For more information: www.cardiarc.com


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now